DK112290D0 - Vaevsplasminogenaktivator-variant - Google Patents
Vaevsplasminogenaktivator-variantInfo
- Publication number
- DK112290D0 DK112290D0 DK112290A DK112290A DK112290D0 DK 112290 D0 DK112290 D0 DK 112290D0 DK 112290 A DK112290 A DK 112290A DK 112290 A DK112290 A DK 112290A DK 112290 D0 DK112290 D0 DK 112290D0
- Authority
- DK
- Denmark
- Prior art keywords
- plasminogen activator
- tissue plasminogen
- activator variant
- variant
- activators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11809887A | 1987-11-06 | 1987-11-06 | |
US11809887 | 1987-11-06 | ||
PCT/US1988/003901 WO1989004368A1 (en) | 1987-11-06 | 1988-11-02 | Novel human tissue-type plasminogen activator variant |
US8803901 | 1988-11-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK112290D0 true DK112290D0 (da) | 1990-05-04 |
DK112290A DK112290A (da) | 1990-07-06 |
DK175482B1 DK175482B1 (da) | 2004-11-08 |
Family
ID=22376492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199001122A DK175482B1 (da) | 1987-11-06 | 1990-05-04 | Human vævsplasminogenaktivator-variant |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP0387290B1 (da) |
JP (1) | JPH03500843A (da) |
KR (1) | KR920009521B1 (da) |
AT (1) | ATE151812T1 (da) |
AU (2) | AU2804989A (da) |
CA (1) | CA1341609C (da) |
DD (1) | DD286613A5 (da) |
DE (1) | DE3855874T2 (da) |
DK (1) | DK175482B1 (da) |
FI (1) | FI102970B (da) |
HU (1) | HU215230B (da) |
IL (1) | IL88247A0 (da) |
NO (1) | NO307612B1 (da) |
NZ (1) | NZ226829A (da) |
PH (1) | PH30064A (da) |
PT (1) | PT88938B (da) |
WO (1) | WO1989004368A1 (da) |
ZA (1) | ZA888250B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0542869T3 (da) * | 1990-07-31 | 1996-02-05 | Genentech Inc | Vævsplasminogenaktivatorvarianter med nedsat udskillelse |
US5246850A (en) * | 1990-07-31 | 1993-09-21 | Genentech, Inc. | DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells |
US5242688A (en) * | 1990-12-24 | 1993-09-07 | Eli Lilly And Company | Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants |
CA2129660C (en) | 1992-06-03 | 2005-06-28 | William F. Bennett | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
US6139838A (en) * | 1996-09-06 | 2000-10-31 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Tissue plasminogen activator medicinal composition |
US7084118B2 (en) | 2002-02-22 | 2006-08-01 | Genentech, Inc. | Combination treatment with t-PA variant and low molecular weight heparin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984001786A1 (en) * | 1982-10-28 | 1984-05-10 | Beecham Group Plc | Enzyme derivatives and their use in the treatment of thrombosis |
DE3789664T3 (de) * | 1986-01-31 | 2004-09-16 | Genetics Institute, LLC, Cambridge | Neue thrombolytische proteine. |
IE81073B1 (en) * | 1986-03-18 | 2000-01-12 | Genentech Inc | Modified human tissue-type plasminogen activator and its preparation |
IL87276A (en) * | 1987-08-03 | 1995-07-31 | Fujisawa Pharmaceutical Co | Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it |
JPH01132377A (ja) * | 1987-10-09 | 1989-05-24 | Monsanto Co | 修正型組織プラスミノーゲンアクチベーター |
-
1988
- 1988-10-31 IL IL88247A patent/IL88247A0/xx unknown
- 1988-11-02 WO PCT/US1988/003901 patent/WO1989004368A1/en active IP Right Grant
- 1988-11-02 EP EP89900085A patent/EP0387290B1/en not_active Expired - Lifetime
- 1988-11-02 DE DE3855874T patent/DE3855874T2/de not_active Expired - Lifetime
- 1988-11-02 KR KR1019890701271A patent/KR920009521B1/ko not_active IP Right Cessation
- 1988-11-02 AT AT89900085T patent/ATE151812T1/de not_active IP Right Cessation
- 1988-11-02 JP JP1500176A patent/JPH03500843A/ja active Pending
- 1988-11-02 HU HU57/89A patent/HU215230B/hu unknown
- 1988-11-02 EP EP96113810A patent/EP0754753A1/en not_active Withdrawn
- 1988-11-02 AU AU28049/89A patent/AU2804989A/en not_active Abandoned
- 1988-11-03 ZA ZA888250A patent/ZA888250B/xx unknown
- 1988-11-03 NZ NZ226829A patent/NZ226829A/en unknown
- 1988-11-04 PH PH37775A patent/PH30064A/en unknown
- 1988-11-04 PT PT88938A patent/PT88938B/pt not_active IP Right Cessation
- 1988-11-07 CA CA582415A patent/CA1341609C/en not_active Expired - Fee Related
- 1988-11-07 DD DD88321544A patent/DD286613A5/de unknown
-
1990
- 1990-05-04 DK DK199001122A patent/DK175482B1/da not_active IP Right Cessation
- 1990-05-04 FI FI902239A patent/FI102970B/fi not_active IP Right Cessation
- 1990-05-04 NO NO901995A patent/NO307612B1/no not_active IP Right Cessation
-
1992
- 1992-08-26 AU AU21317/92A patent/AU658909B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI102970B1 (fi) | 1999-03-31 |
AU2131792A (en) | 1992-11-19 |
DK112290A (da) | 1990-07-06 |
KR890701733A (ko) | 1989-12-21 |
PH30064A (en) | 1996-11-08 |
ZA888250B (en) | 1990-07-25 |
WO1989004368A1 (en) | 1989-05-18 |
HU215230B (hu) | 2000-03-28 |
PT88938B (pt) | 1993-05-31 |
ATE151812T1 (de) | 1997-05-15 |
DE3855874D1 (de) | 1997-05-22 |
EP0754753A1 (en) | 1997-01-22 |
KR920009521B1 (ko) | 1992-10-17 |
DE3855874T2 (de) | 1997-09-11 |
HUT54209A (en) | 1991-01-28 |
JPH03500843A (ja) | 1991-02-28 |
PT88938A (pt) | 1989-11-30 |
NZ226829A (en) | 1991-06-25 |
DD286613A5 (de) | 1991-01-31 |
IL88247A0 (en) | 1989-06-30 |
EP0387290A1 (en) | 1990-09-19 |
EP0387290B1 (en) | 1997-04-16 |
DK175482B1 (da) | 2004-11-08 |
NO307612B1 (no) | 2000-05-02 |
AU658909B2 (en) | 1995-05-04 |
HU890157D0 (en) | 1990-12-28 |
AU2804989A (en) | 1989-06-01 |
FI902239A0 (fi) | 1990-05-04 |
FI102970B (fi) | 1999-03-31 |
CA1341609C (en) | 2011-02-01 |
NO901995D0 (no) | 1990-05-04 |
NO901995L (no) | 1990-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3751842D1 (de) | Modifizierter, menschlicher Gewebeplasminogenaktivator und seine Herstellung | |
IL80659A0 (en) | Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them | |
NZ223028A (en) | Enkephalinase; compositions and assay | |
DK112290A (da) | Vaevsplasminogenaktivator-variant | |
DE59008693D1 (de) | Gewebs-Plasminogen-Aktivator-Derivat. | |
NO880831D0 (no) | Rekombinant human vevsplasminogen-aktivatorblanding. | |
IL109759A0 (en) | Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life | |
IE870208L (en) | Modified tissue plasminogen activator | |
AU7554687A (en) | Modified tissue plasminogen activator | |
IE871856L (en) | "modified tissue plasminogen activator" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |